AB Science S.A. (ABSCF) Financials Nov 13, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for AB Science S.A.
Fiscal year is January-December. All values EUR millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 316,000 917,000 1.1M 1.34M 1.93M
Cost of Goods Sold (COGS) incl. D&A 480,000 626,000 647,000 238,000 331,000
COGS excluding D&A 150,000 377,000 301,000 33,000 6,000
Depreciation & Amortization Expense 330,000 249,000 346,000 205,000 325,000
Depreciation 82,000 89,000 69,000 52,000 68,000
Amortization of Intangibles 248,000 160,000 277,000 153,000 257,000
Gross Income (164,000) 291,000 457,000 1.1M 1.6M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 8.21M 10.14M 10.17M 11.72M 15.37M
Research & Development 5.83M 7.99M 7.59M 8.73M 12.12M
Other SG&A 2.38M 2.15M 2.59M 2.99M 3.26M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 37,000 201,000 15,000 (118,000) (141,000)
Non-Operating Interest Income 234,000 164,000 292,000 360,000 256,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense - - 257,000 653,000 1M
Gross Interest Expense - - 257,000 1.11M 1.84M
Interest Capitalized 0 0 0 456,000 840,000
Pretax Income (8.1M) (9.49M) (9.67M) (11.02M) (14.66M)
Income Tax 6,000 2,000 (15,000) (39,000) (48,000)
Income Tax - Current Domestic 6,000 - - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits - - - - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (8.11M) (9.49M) (9.65M) (10.99M) (14.61M)
Minority Interest Expense 0 0 0 0 0
Net Income (8.11M) (9.49M) (9.65M) (10.99M) (14.61M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (8.11M) (9.49M) (9.65M) (10.99M) (14.61M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (8.11M) (9.49M) (9.65M) (10.99M) (14.61M)
EPS (Basic) (0.27) (0.32) (0.31) (0.34) (0.45)
Basic Shares Outstanding 29.93M 29.9M 31.4M 32.2M 32.83M
EPS (Diluted) (0.27) (0.32) (0.31) (0.34) (0.45)
Diluted Shares Outstanding 29.93M 29.9M 31.4M 32.2M 32.83M
EBITDA (8.05M) (9.6M) (9.37M) (10.41M) (13.45M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for AB Science S.A.
Fiscal year is January-December. All values EUR millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 316,000 917,000 1.1M 1.34M 1.93M
Cost of Goods Sold (COGS) incl. D&A 480,000 626,000 647,000 238,000 331,000
COGS excluding D&A 150,000 377,000 301,000 33,000 6,000
Depreciation & Amortization Expense 330,000 249,000 346,000 205,000 325,000
Depreciation 82,000 89,000 69,000 52,000 68,000
Amortization of Intangibles 248,000 160,000 277,000 153,000 257,000
Gross Income (164,000) 291,000 457,000 1.1M 1.6M
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 8.21M 10.14M 10.17M 11.72M 15.37M
Research & Development 5.83M 7.99M 7.59M 8.73M 12.12M
Other SG&A 2.38M 2.15M 2.59M 2.99M 3.26M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 37,000 201,000 15,000 (118,000) (141,000)
Non-Operating Interest Income 234,000 164,000 292,000 360,000 256,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense - - 257,000 653,000 1M
Gross Interest Expense - - 257,000 1.11M 1.84M
Interest Capitalized 0 0 0 456,000 840,000
Pretax Income (8.1M) (9.49M) (9.67M) (11.02M) (14.66M)
Income Tax 6,000 2,000 (15,000) (39,000) (48,000)
Income Tax - Current Domestic 6,000 - - - -
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits - - - - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (8.11M) (9.49M) (9.65M) (10.99M) (14.61M)
Minority Interest Expense 0 0 0 0 0
Net Income (8.11M) (9.49M) (9.65M) (10.99M) (14.61M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (8.11M) (9.49M) (9.65M) (10.99M) (14.61M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (8.11M) (9.49M) (9.65M) (10.99M) (14.61M)
EPS (Basic) (0.27) (0.32) (0.31) (0.34) (0.45)
Basic Shares Outstanding 29.93M 29.9M 31.4M 32.2M 32.83M
EPS (Diluted) (0.27) (0.32) (0.31) (0.34) (0.45)
Diluted Shares Outstanding 29.93M 29.9M 31.4M 32.2M 32.83M
EBITDA (8.05M) (9.6M) (9.37M) (10.41M) (13.45M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
